Gene Editing Patent Application Trends 2024

Gene Editing patent applications in 2024

Top Technology Areas in Gene Editing

Top CPC Codes

• C12N9/22 (No explanation available)
  • Count: 337 patents
  • Example: 20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation)
• C12N2310/20 (No explanation available)
  • Count: 312 patents
  • Example: 20240226246. NOVEL OMNI-50 CRISPR NUCLEASE simplified abstract (EmendoBio Inc.)
• C12N15/86 (No explanation available)
  • Count: 207 patents
  • Example: 20240226326. COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS simplified abstract (Decibel Therapeutics, Inc.)
• C12N15/11 (No explanation available)
  • Count: 176 patents
  • Example: 20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation)
• C12N2750/14143 (No explanation available)
  • Count: 142 patents
  • Example: 20240226332. GENE THERAPY FOR TREM2-ASSOCIATED DISEASES AND DISORDERS simplified abstract (Eli Lilly and Company)
• C12N15/907 (No explanation available)
  • Count: 104 patents
  • Example: 20240226246. NOVEL OMNI-50 CRISPR NUCLEASE simplified abstract (EmendoBio Inc.)
• A61K48/005 (No explanation available)
  • Count: 95 patents
  • Example: 20240226326. COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS simplified abstract (Decibel Therapeutics, Inc.)
• C12N2800/80 (No explanation available)
  • Count: 92 patents
  • Example: 20240226246. NOVEL OMNI-50 CRISPR NUCLEASE simplified abstract (EmendoBio Inc.)
• C12N15/111 (No explanation available)
  • Count: 78 patents
  • Example: 20240226334. CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS WITH ALL-IN-ONE ADENO-ASSOCIATED VIRUS-DELIVERED SINGLE-CUT CRISPR simplified abstract (The Board of Regents of The University of Texas System)
• C12N15/113 (No explanation available)
  • Count: 75 patents
  • Example: 20240228546. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM))

Top Companies in Gene Editing

The Broad Institute, Inc.

• Number of Gene Editing patents: 21
• Top CPC codes:
  • C12N9/22 (No explanation available): 16 patents
  • C12N2310/20 (No explanation available): 16 patents
  • C12N15/907 (No explanation available): 11 patents
• Recent patents:
  • 20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES simplified abstract (The Broad Institute, Inc.) (20241003)
  • 20240327933. CORONAVIRUS RAPID DIAGNOSTICS simplified abstract (The Broad Institute, Inc.) (20241003)
  • 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.) (20240208)

The Regents of the University of California

• Number of Gene Editing patents: 17
• Top CPC codes:
  • C12N9/22 (No explanation available): 9 patents
  • C12N2310/20 (No explanation available): 8 patents
  • C12N15/11 (No explanation available): 6 patents
• Recent patents:
  • 20240216541. GENE THERAPY FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY simplified abstract (The Regents of the University of California) (20240704)
  • 20240023528. ONE-LOCUS INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE OR TEMPERATURE-INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE simplified abstract (The Regents of the University of California) (20240125)
  • 20240026321. CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (The Regents of the University of California) (20240125)

Mammoth Biosciences, Inc.

• Number of Gene Editing patents: 11
• Top CPC codes:
  • C12N9/22 (No explanation available): 8 patents
  • C12N15/11 (No explanation available): 6 patents
  • C12N2310/20 (No explanation available): 6 patents
• Recent patents:
  • 20240084275. COMPOSITIONS AND METHODS OF USING PROGRAMMABLE NUCLEASES FOR INDUCING CELL DEATH simplified abstract (Mammoth Biosciences, Inc.) (20240314)
  • 20240218393. VECTORS ENCODING GENE EDITING SYSTEMS AND USES THEREOF simplified abstract (Mammoth Biosciences, Inc.) (20240704)
  • 20240327812. FUSION EFFECTOR PROTEINS AND USES THEREOF simplified abstract (Mammoth Biosciences, Inc.) (20241003)

The Trustees of the University of Pennsylvania

• Number of Gene Editing patents: 11
• Top CPC codes:
  • C12N15/86 (No explanation available): 7 patents
  • A61K48/005 (No explanation available): 5 patents
  • C12N2750/14143 (No explanation available): 5 patents
• Recent patents:
  • 20240218394. GENE THERAPY FOR OCULAR DISORDERS simplified abstract (The Trustees of the University of Pennsylvania) (20240704)
  • 20240316107. Compositions and Methods for Gene Editing in T Cells Using CRISPR/Cpf1 simplified abstract (The Trustees of the University of Pennsylvania) (20240926)
  • 20240024510. GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE I simplified abstract (The Trustees of the University of Pennsylvania) (20240125)

UNIVERSITY OF MASSACHUSETTS

• Number of Gene Editing patents: 9
• Top CPC codes:
  • C12N9/22 (No explanation available): 6 patents
  • C12N2310/20 (No explanation available): 5 patents
  • C12N15/907 (No explanation available): 4 patents
• Recent patents:
  • 20240018479. METHODS AND COMPOSITIONS FOR TREATMENT OF MUSCLE DISEASE WITH IPSC-INDUCED HUMAN SKELETAL MUSCLE STEM CELLS simplified abstract (UNIVERSITY OF MASSACHUSETTS) (20240118)
  • 20240175056. PRIME EDITING-BASED SIMULTANEOUS GENOMIC DELETION AND INSERTION simplified abstract (UNIVERSITY OF MASSACHUSETTS) (20240530)
  • 20240167029. MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING simplified abstract (UNIVERSITY OF MASSACHUSETTS) (20240523)

Duke University

• Number of Gene Editing patents: 8
• Top CPC codes:
  • C12N9/22 (No explanation available): 5 patents
  • C12N15/86 (No explanation available): 4 patents
  • C12N2750/14143 (No explanation available): 4 patents
• Recent patents:
  • 20240141325. GENERATION OF NOVEL CRISPR GENOME EDITING AGENTS USING COMBINATORIAL CHEMISTRY simplified abstract (Duke University) (20240502)
  • 20240108754. COMPOSITIONS COMPRISING NOVEL PROKARYOTIC SODIUM CHANNELS AND ASSOCIATED METHODS simplified abstract (Duke University) (20240404)
  • 20240026352. TARGETED GENE REGULATION OF HUMAN IMMUNE CELLS WITH CRISPR-CAS SYSTEMS simplified abstract (Duke University) (20240125)

THE BROAD INSTITUTE, INC.

• Number of Gene Editing patents: 8
• Top CPC codes:
  • C12N2310/20 (No explanation available): 7 patents
  • C12N9/22 (No explanation available): 6 patents
  • C12N15/102 (No explanation available): 4 patents
• Recent patents:
  • 20240110165. NOVEL TYPE VI CRISPR ORTHOLOGS AND SYSTEMS simplified abstract (THE BROAD INSTITUTE, INC.) (20240404)
  • 20240318165. TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS simplified abstract (THE BROAD INSTITUTE, INC.) (20240926)
  • 20240043828. T-DNA MEDIATED GENETIC MODIFICATION simplified abstract (THE BROAD INSTITUTE, INC.) (20240208)

Arbor Biotechnologies, Inc.

• Number of Gene Editing patents: 8
• Top CPC codes:
  • C12N9/22 (No explanation available): 8 patents
  • C12N2310/20 (No explanation available): 8 patents
  • C12N15/86 (No explanation available): 4 patents
• Recent patents:
  • 20240301447. GENE EDITING METHOD FOR INHIBITING ABERRANT SPLICING IN STATHMIN 2 (STMN2) TRANSCRIPT simplified abstract (Arbor Biotechnologies, Inc.) (20240912)
  • 20240261435. GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING TRANSTHYRETIN (TTR) AND USES THEREOF simplified abstract (Arbor Biotechnologies, Inc.) (20240808)
  • 20240011004. COMPOSITIONS COMPRISING A VARIANT CRISPR NUCLEASE POLYPEPTIDE AND USES THEREOF simplified abstract (Arbor Biotechnologies, Inc.) (20240111)

INBIOSE N.V.

• Number of Gene Editing patents: 8
• Top CPC codes:
  • C12N9/1081 (No explanation available): 5 patents
  • C12P19/12 (No explanation available): 4 patents
  • C12N9/1051 (No explanation available): 4 patents
• Recent patents:
  • 20240191270. FERMENTATIVE PRODUCTION simplified abstract (INBIOSE N.V.) (20240613)
  • 20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.) (20240314)
  • 20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES simplified abstract (INBIOSE N.V.) (20241003)

Massachusetts Institute of Technology

• Number of Gene Editing patents: 7
• Top CPC codes:
  • C12N9/22 (No explanation available): 6 patents
  • C12N2310/20 (No explanation available): 6 patents
  • C12N15/111 (No explanation available): 4 patents
• Recent patents:
  • 20240067957. AUTOCATALYTIC BASE EDITING FOR RNA-RESPONSIVE TRANSLATIONAL CONTROL simplified abstract (Massachusetts Institute of Technology) (20240229)
  • 20240067961. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) simplified abstract (Massachusetts Institute of Technology) (20240229)
  • 20240035031. TARGETED TRANS-SPLICING USING CRISPR/CAS13 simplified abstract (Massachusetts Institute of Technology) (20240201)

New Companies in Gene Editing (Last Month)

800px

No new companies detected in the last month.

Emerging Technology Areas in Gene Editing

• G06N3/088 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• G06F18/2413 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• G06F18/295 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• G06F18/231 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• G16B40/30 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• G09B19/00 (No explanation available)
  • Count: 1 patents
  • Example: 20240046217. TALENT MOBILITY PLATFORM simplified abstract (ADP, Inc.)
• A61L2430/02 (No explanation available)
  • Count: 1 patents
  • Example: 20240043818. Engineered Cells for Increased Collagen Production simplified abstract (Northeastern University)
• A61L2430/16 (No explanation available)
  • Count: 1 patents
  • Example: 20240043818. Engineered Cells for Increased Collagen Production simplified abstract (Northeastern University)
• A61L26/0033 (No explanation available)
  • Count: 1 patents
  • Example: 20240043818. Engineered Cells for Increased Collagen Production simplified abstract (Northeastern University)
• A61L27/24 (No explanation available)
  • Count: 1 patents
  • Example: 20240043818. Engineered Cells for Increased Collagen Production simplified abstract (Northeastern University)

Top Companies in Emerging Gene Editing Technologies

• The Broad Institute, Inc.: 5 patents
• Northeastern University: 4 patents
• ADP, Inc.: 1 patents

Top Inventors in Gene Editing

Feng Zhang of Cambridge MA (US)

• Number of Gene Editing patents: 19
• Top companies:
  • The Broad Institute, Inc.: 12 patents
  • THE BROAD INSTITUTE, INC.: 7 patents
• Recent patents:
  • 20240318165. TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS simplified abstract (THE BROAD INSTITUTE, INC.) (20240926)
  • 20240043828. T-DNA MEDIATED GENETIC MODIFICATION simplified abstract (THE BROAD INSTITUTE, INC.) (20240208)
  • 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.) (20240208)

Joeri Beauprez

• Number of Gene Editing patents: 8
• Top companies:
  • INBIOSE N.V.: 8 patents
• Recent patents:
  • 20240191270. FERMENTATIVE PRODUCTION simplified abstract (INBIOSE N.V.) (20240613)
  • 20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.) (20240314)
  • 20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES simplified abstract (INBIOSE N.V.) (20241003)

Benjamin Julius RAUCH of San Francisco CA (US)

• Number of Gene Editing patents: 7
• Top companies:
  • Mammoth Biosciences, Inc.: 7 patents
• Recent patents:
  • 20240173433. PROGRAMMABLE NUCLEASES AND METHODS OF USE simplified abstract (Mammoth Biosciences, Inc.) (20240530)
  • 20240191280. ENHANCED GUIDE NUCLEIC ACIDS AND METHODS OF USE simplified abstract (Mammoth Biosciences, Inc.) (20240613)
  • 20240191281. PROGRAMMABLE NUCLEASES AND METHODS OF USE simplified abstract (Mammoth Biosciences, Inc.) (20240613)

Jonathan Gootenberg of Cambridge MA (US)

• Number of Gene Editing patents: 7
• Top companies:
  • Massachusetts Institute of Technology: 4 patents
  • The Broad Institute, Inc.: 2 patents
  • MASSACHUSETTS INSTITUTE OF TECHNOLOGY: 1 patents
• Recent patents:
  • 20240067961. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) simplified abstract (Massachusetts Institute of Technology) (20240229)
  • 20240191223. TYPE VI CRISPR ORTHOLOGS AND SYSTEMS simplified abstract (The Broad Institute, Inc.) (20240613)
  • 20240327933. CORONAVIRUS RAPID DIAGNOSTICS simplified abstract (The Broad Institute, Inc.) (20241003)

David R. Liu of Cambridge MA (US)

• Number of Gene Editing patents: 7
• Top companies:
  • The Broad Institute, Inc.: 3 patents
  • President and Fellows of Harvard College: 2 patents
  • President and Fellows of Harvard College: 1 patents
• Recent patents:
  • 20240344055. METHODS AND SYSTEMS FOR MODIFYING THE CRUMBS HOMOLOGUE-1 (CRB1) GENE simplified abstract (The Trustees of Columbia University in the City of New York) (20241017)
  • 20240110166. EDITING OF CCR5 RECEPTOR GENE TO PROTECT AGAINST HIV INFECTION simplified abstract (President and Fellows of Harvard College) (20240404)
  • 20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES simplified abstract (The Broad Institute, Inc.) (20241003)

Sean HIGGINS of Alameda CA (US)

• Number of Gene Editing patents: 7
• Top companies:
  • Scribe Therapeutics Inc.: 7 patents
• Recent patents:
  • 20240033377. AAV VECTORS FOR GENE EDITING simplified abstract (Scribe Therapeutics Inc.) (20240201)
  • 20240026385. ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS simplified abstract (Scribe Therapeutics Inc.) (20240125)
  • 20240026386. COMPOSITIONS AND METHODS FOR THE TARGETING OF BCL11A simplified abstract (Scribe Therapeutics Inc.) (20240125)

Sarah DENNY of San Francisco CA (US)

• Number of Gene Editing patents: 7
• Top companies:
  • Scribe Therapeutics Inc.: 7 patents
• Recent patents:
  • 20240033377. AAV VECTORS FOR GENE EDITING simplified abstract (Scribe Therapeutics Inc.) (20240201)
  • 20240026385. ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS simplified abstract (Scribe Therapeutics Inc.) (20240125)
  • 20240026386. COMPOSITIONS AND METHODS FOR THE TARGETING OF BCL11A simplified abstract (Scribe Therapeutics Inc.) (20240125)

Benjamin OAKES of El Cerrito CA (US)

• Number of Gene Editing patents: 7
• Top companies:
  • Scribe Therapeutics Inc.: 7 patents
• Recent patents:
  • 20240033377. AAV VECTORS FOR GENE EDITING simplified abstract (Scribe Therapeutics Inc.) (20240201)
  • 20240026385. ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS simplified abstract (Scribe Therapeutics Inc.) (20240125)
  • 20240026386. COMPOSITIONS AND METHODS FOR THE TARGETING OF BCL11A simplified abstract (Scribe Therapeutics Inc.) (20240125)

Omar Abudayyeh of Cambridge MA (US)

• Number of Gene Editing patents: 6
• Top companies:
  • Massachusetts Institute of Technology: 4 patents
  • MASSACHUSETTS INSTITUTE OF TECHNOLOGY: 1 patents
  • The Broad Institute, Inc.: 1 patents
• Recent patents:
  • 20240132883. RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX simplified abstract (Massachusetts Institute of Technology) (20240425)
  • 20240093193. DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS simplified abstract (The Broad Institute, Inc.) (20240321)
  • 20240067961. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) simplified abstract (Massachusetts Institute of Technology) (20240229)

Lucas Benjamin HARRINGTON of San Francisco CA (US)

• Number of Gene Editing patents: 6
• Top companies:
  • Mammoth Biosciences, Inc.: 6 patents
• Recent patents:
  • 20240084275. COMPOSITIONS AND METHODS OF USING PROGRAMMABLE NUCLEASES FOR INDUCING CELL DEATH simplified abstract (Mammoth Biosciences, Inc.) (20240314)
  • 20240218393. VECTORS ENCODING GENE EDITING SYSTEMS AND USES THEREOF simplified abstract (Mammoth Biosciences, Inc.) (20240704)
  • 20240327812. FUSION EFFECTOR PROTEINS AND USES THEREOF simplified abstract (Mammoth Biosciences, Inc.) (20241003)

James M. Wilson of Philadelphia PA (US)

• Number of Gene Editing patents: 6
• Top companies:
  • The Trustees of the University of Pennsylvania: 6 patents
• Recent patents:
  • 20240197916. COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED GENE TARGETING FOR THE TREATMENT OF GENETIC DISORDERS simplified abstract (The Trustees of the University of Pennsylvania) (20240620)
  • 20240016903. GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II simplified abstract (The Trustees of the University of Pennsylvania) (20240118)
  • 20240024510. GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE I simplified abstract (The Trustees of the University of Pennsylvania) (20240125)

Aaron DELOUGHERY of San Francisco CA (US)

• Number of Gene Editing patents: 5
• Top companies:
  • Mammoth Biosciences, Inc.: 5 patents
• Recent patents:
  • 20240175059. EFFECTOR PROTEINS AND METHODS OF USE simplified abstract (Mammoth Biosciences, Inc.) (20240530)
  • 20240191280. ENHANCED GUIDE NUCLEIC ACIDS AND METHODS OF USE simplified abstract (Mammoth Biosciences, Inc.) (20240613)
  • 20240191281. PROGRAMMABLE NUCLEASES AND METHODS OF USE simplified abstract (Mammoth Biosciences, Inc.) (20240613)

David PAEZ-ESPINO of Concord CA (US)

• Number of Gene Editing patents: 5
• Top companies:
  • Mammoth Biosciences, Inc.: 5 patents
• Recent patents:
  • 20240271113. EFFECTOR PROTEINS AND METHODS OF USE simplified abstract (Mammoth Biosciences, Inc.) (20240815)
  • 20240131187. EFFECTOR PROTEINS, EFFECTOR PARTNERS, COMPOSITIONS, SYSTEMS AND METHODS OF USE THEREOF simplified abstract (Mammoth Biosciences, Inc.) (20240425)
  • 20240191281. PROGRAMMABLE NUCLEASES AND METHODS OF USE simplified abstract (Mammoth Biosciences, Inc.) (20240613)

Chenglong HAO

• Number of Gene Editing patents: 5
• Top companies:
  • SHENZHEN METALENX TECHNOLOGY CO.,LTD: 5 patents
• Recent patents:
  • 20240345463. POINT CLOUD PROJECTION SYSTEM simplified abstract (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20241017)
  • 20240315540. ENDOSCOPIC PROBE, ENDOSCOPE AND METHOD OF SCANNING CONTROL simplified abstract (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20240926)
  • 20240319016. METALENS ARRAY AND WAVEFRONT SENSOR SYSTEM simplified abstract (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20240926)

Fengze TAN

• Number of Gene Editing patents: 5
• Top companies:
  • SHENZHEN METALENX TECHNOLOGY CO.,LTD: 5 patents
• Recent patents:
  • 20240345463. POINT CLOUD PROJECTION SYSTEM simplified abstract (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20241017)
  • 20240315540. ENDOSCOPIC PROBE, ENDOSCOPE AND METHOD OF SCANNING CONTROL simplified abstract (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20240926)
  • 20240319016. METALENS ARRAY AND WAVEFRONT SENSOR SYSTEM simplified abstract (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20240926)

Jian ZHU

• Number of Gene Editing patents: 5
• Top companies:
  • SHENZHEN METALENX TECHNOLOGY CO.,LTD: 5 patents
• Recent patents:
  • 20240345463. POINT CLOUD PROJECTION SYSTEM simplified abstract (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20241017)
  • 20240315540. ENDOSCOPIC PROBE, ENDOSCOPE AND METHOD OF SCANNING CONTROL simplified abstract (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20240926)
  • 20240319016. METALENS ARRAY AND WAVEFRONT SENSOR SYSTEM simplified abstract (SHENZHEN METALENX TECHNOLOGY CO.,LTD) (20240926)

Natalia SAVELIEVA

• Number of Gene Editing patents: 5
• Top companies:
  • CELL AND GENE THERAPY LTD: 5 patents
• Recent patents:
  • [[20240269324. Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of ANG, ANGPT1, VEGFA, FGF1, HIF1a, HGF, SDF1, KLK4, PDGFC, PROK1, and PROK2 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-ANG, or Escherichia coli strain SCS110-AF/VTvaf17-ANGPT1, or Escherichia coli strain SCS110-AF/VTvaf17-VEGFA, or Escherichia coli strain SCS110-AF/VTvaf17-FGF simplified abstract (CELL AND GENE THERAPY LTD)]] (20240815)
  • [[20240060083. Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of SHH, CTNNB1, NOG, and WNT7A genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-SHH, or Escherichia coli strain SCS110-AF/VTvaf17-CTNNB1, or Escherichia coli strain SCS110-AF/VTvaf17-NOG, or Escherichia coli strain SCS110-AF/VTvaf17-WNT7A carrying the gene therapy DNA vector, method simplified abstract (CELL AND GENE THERAPY LTD)]] (20240222)
  • [[20240325569. Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of BDNF, VEGFA, BFGF, NGF, GDNF, NT3, CNTF, and IGF1 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-BDNF, or Escherichia coli strain SCS110-AF/VTvaf17-VEGFA, or Escherichia coli strain SCS110-AF/VTvaf17-BFGF, or Escherichia coli strain SCS110-AF/VTvaf17-NGF, or Escherichia coli str simplified abstract (CELL AND GENE THERAPY LTD)]] (20241003)

Feng ZHANG of Cambridge MA (US)

• Number of Gene Editing patents: 5
• Top companies:
  • The Broad Institute, Inc.: 5 patents
• Recent patents:
  • 20240035007. SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS simplified abstract (The Broad Institute, Inc.) (20240201)
  • 20240035048. DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS simplified abstract (The Broad Institute, Inc.) (20240201)
  • 20240084364. CRISPR ENZYMES AND SYSTEMS simplified abstract (The Broad Institute, Inc.) (20240314)

Anurup Ganguli of San Diego CA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • VedaBio, Inc.: 4 patents
• Recent patents:
  • 20240254463. ENGINEERED STABLE NUCLEIC ACID-GUIDED NUCLEASES simplified abstract (VedaBio, Inc.) (20240801)
  • 20240344044. DELIVERY OF THERAPEUTICS IN VIVO VIA A CRISPR-BASED CASCADE SYSTEM simplified abstract (VedaBio, Inc.) (20241017)
  • 20240110164. DELIVERY OF THERAPEUTICS IN VIVO VIA A CRISPR-BASED CASCADE SYSTEM simplified abstract (VedaBio, Inc.) (20240404)

Noah Michael Jakimo of Cambridge MA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • Arbor Biotechnologies, Inc.: 4 patents
• Recent patents:
  • 20240301371. CRISPR-ASSOCIATED TRANSPOSON SYSTEMS AND METHODS OF USING SAME simplified abstract (Arbor Biotechnologies, Inc.) (20240912)
  • 20240301445. CRISPR-ASSOCIATED TRANSPOSON SYSTEMS AND METHODS OF USING SAME simplified abstract (Arbor Biotechnologies, Inc.) (20240912)
  • 20240261435. GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING TRANSTHYRETIN (TTR) AND USES THEREOF simplified abstract (Arbor Biotechnologies, Inc.) (20240808)

Kevin Flanigan of Columbus OH (US)

• Number of Gene Editing patents: 4
• Top companies:
  • RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL: 4 patents
• Recent patents:
  • 20240261434. PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY simplified abstract (RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL) (20240808)
  • 20240200066. PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY simplified abstract (RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL) (20240620)
  • 20240189453. MATERIALS AND METHODS FOR NEUROFIBROMIN 2/MERLIN (NF2) GENE THERAPY simplified abstract (RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL) (20240613)

Manu Tamminen

• Number of Gene Editing patents: 4
• Top companies:
  • Genomill Health Oy: 3 patents
  • EAWAG, SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY: 1 patents
• Recent patents:
  • 20240158843. ACCURATE AND MASSIVELY PARALLEL QUANTIFICATION OF NUCLEIC ACID simplified abstract (EAWAG, SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY) (20240516)
  • 20240068010. HIGHLY SENSITIVE METHODS FOR ACCURATE PARALLEL QUANTIFICATION OF VARIANT NUCLEIC ACIDS simplified abstract (Genomill Health Oy) (20240229)
  • 20240068022. METHODS FOR ACCURATE PARALLEL DETECTION AND QUANTIFICATION OF NUCLEIC ACIDS simplified abstract (Genomill Health Oy) (20240229)

Pieter Coussement

• Number of Gene Editing patents: 4
• Top companies:
  • INBIOSE N.V.: 4 patents
• Recent patents:
  • 20240200021. CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.) (20240620)
  • 20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.) (20240627)
  • 20240191270. FERMENTATIVE PRODUCTION simplified abstract (INBIOSE N.V.) (20240613)

Thomas Decoene

• Number of Gene Editing patents: 4
• Top companies:
  • INBIOSE N.V.: 4 patents
• Recent patents:
  • 20240200021. CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.) (20240620)
  • 20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.) (20240627)
  • 20240191270. FERMENTATIVE PRODUCTION simplified abstract (INBIOSE N.V.) (20240613)

Annelies Vercauteren

• Number of Gene Editing patents: 4
• Top companies:
  • INBIOSE N.V.: 4 patents
• Recent patents:
  • 20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.) (20240627)
  • 20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES simplified abstract (INBIOSE N.V.) (20240201)
  • 20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES simplified abstract (INBIOSE N.V.) (20241003)

Brett T. STAAHL of Tiburon CA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • Scribe Therapeutics Inc.: 4 patents
• Recent patents:
  • 20240033377. AAV VECTORS FOR GENE EDITING simplified abstract (Scribe Therapeutics Inc.) (20240201)
  • 20240026385. ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS simplified abstract (Scribe Therapeutics Inc.) (20240125)
  • 20240026386. COMPOSITIONS AND METHODS FOR THE TARGETING OF BCL11A simplified abstract (Scribe Therapeutics Inc.) (20240125)

Kamel KHALILI of Bala Cynwyd PA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION: 2 patents
  • Temple University - of the Commonwealth System of Higher Education: 2 patents
• Recent patents:
  • 20240271128. RNA GUIDED ERADICATION OF HERPES SIMPLEX TYPE I AND OTHER RELATED HUMAN HERPESVIRUSES simplified abstract (Temple University - of the Commonwealth System of Higher Education) (20240815)
  • 20240336939. CRISPR INDUCED DISRUPTION OF MOGS GENE simplified abstract (TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION) (20241010)
  • 20240139294. METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION simplified abstract (Temple University - of the Commonwealth System of Higher Education) (20240502)

Christian Hinderer of Baltimore MD (US)

• Number of Gene Editing patents: 4
• Top companies:
  • The Trustees of the University of Pennsylvania: 4 patents
• Recent patents:
  • 20240307511. AAV9-MEDIATED GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE I simplified abstract (The Trustees of the University of Pennsylvania) (20240919)
  • 20240016903. GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II simplified abstract (The Trustees of the University of Pennsylvania) (20240118)
  • 20240024510. GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE I simplified abstract (The Trustees of the University of Pennsylvania) (20240125)

Christopher BROWN of Albany CA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • Metagenomi, Inc.: 4 patents
• Recent patents:
  • 20240309404. BASE EDITING ENZYMES simplified abstract (Metagenomi, Inc.) (20240919)
  • 20240336905. CLASS II, TYPE V CRISPR SYSTEMS simplified abstract (Metagenomi, Inc.) (20241010)
  • 20240218339. CLASS II, TYPE V CRISPR SYSTEMS simplified abstract (Metagenomi, Inc.) (20240704)

Alim Ladha of Cambridge MA (US)

• Number of Gene Editing patents: 4
• Top companies:
  • ReNAgade Therapeutics Management Inc.: 2 patents
  • The Broad Institute, Inc.: 1 patents
  • THE BROAD INSTITUTE, INC.: 1 patents
• Recent patents:
  • 20240141382. GENE EDITING COMPONENTS, SYSTEMS, AND METHODS OF USE simplified abstract (ReNAgade Therapeutics Management Inc.) (20240502)
  • 20240084274. GENE EDITING COMPONENTS, SYSTEMS, AND METHODS OF USE simplified abstract (ReNAgade Therapeutics Management Inc.) (20240314)
  • 20240043828. T-DNA MEDIATED GENETIC MODIFICATION simplified abstract (THE BROAD INSTITUTE, INC.) (20240208)

AMIR HASSAN FIROOZI

• Number of Gene Editing patents: 4
• Top companies:
  • Chiun Mai Communication Systems, Inc.: 4 patents
• Recent patents:
  • 20240241290. METALENS ARRAY AND DISPLAY DEVICE HAVING SAME simplified abstract (Chiun Mai Communication Systems, Inc.) (20240718)
  • 20240241293. METALENS ARRAY AND DISPLAY DEVICE HAVING SAME simplified abstract (Chiun Mai Communication Systems, Inc.) (20240718)
  • 20240241380. METALENS ARRAY AND DISPLAY DEVICE HAVING SAME simplified abstract (Chiun Mai Communication Systems, Inc.) (20240718)

CHEN-SHENG HSU

• Number of Gene Editing patents: 4
• Top companies:
  • Chiun Mai Communication Systems, Inc.: 4 patents
• Recent patents:
  • 20240241290. METALENS ARRAY AND DISPLAY DEVICE HAVING SAME simplified abstract (Chiun Mai Communication Systems, Inc.) (20240718)
  • 20240241293. METALENS ARRAY AND DISPLAY DEVICE HAVING SAME simplified abstract (Chiun Mai Communication Systems, Inc.) (20240718)
  • 20240241380. METALENS ARRAY AND DISPLAY DEVICE HAVING SAME simplified abstract (Chiun Mai Communication Systems, Inc.) (20240718)

Lior Izhar

• Number of Gene Editing patents: 3
• Top companies:
  • EmendoBio Inc.: 3 patents
• Recent patents:
  • 20240226246. NOVEL OMNI-50 CRISPR NUCLEASE simplified abstract (EmendoBio Inc.) (20240711)
  • 20240002840. NOVEL OMNI-50 CRISPR NUCLEASE-RNA COMPLEXES simplified abstract (EmendoBio Inc.) (20240104)
  • 20240131121. NOVEL OMNI-50 CRISPR NUCLEASE simplified abstract (EmendoBio Inc.) (20240425)

Liat Rockah

• Number of Gene Editing patents: 3
• Top companies:
  • EmendoBio Inc.: 3 patents
• Recent patents:
  • 20240226246. NOVEL OMNI-50 CRISPR NUCLEASE simplified abstract (EmendoBio Inc.) (20240711)
  • 20240002840. NOVEL OMNI-50 CRISPR NUCLEASE-RNA COMPLEXES simplified abstract (EmendoBio Inc.) (20240104)
  • 20240131121. NOVEL OMNI-50 CRISPR NUCLEASE simplified abstract (EmendoBio Inc.) (20240425)

Adam PALERMO of Somerville MA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Decibel Therapeutics, Inc.: 3 patents
• Recent patents:
  • 20240226326. COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS simplified abstract (Decibel Therapeutics, Inc.) (20240711)
  • 20240131186. COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS simplified abstract (Decibel Therapeutics, Inc.) (20240425)
  • 20240148905. METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS simplified abstract (Decibel Therapeutics, Inc.) (20240509)

Jonathon WHITTON of Cambridge MA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Decibel Therapeutics, Inc.: 3 patents
• Recent patents:
  • 20240226326. COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS simplified abstract (Decibel Therapeutics, Inc.) (20240711)
  • 20240131186. COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS simplified abstract (Decibel Therapeutics, Inc.) (20240425)
  • 20240148905. METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS simplified abstract (Decibel Therapeutics, Inc.) (20240509)

Eric N. OLSON of Dallas TX (US)

• Number of Gene Editing patents: 3
• Top companies:
  • The Board of Regents of The University of Texas System: 3 patents
• Recent patents:
  • 20240226334. CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS WITH ALL-IN-ONE ADENO-ASSOCIATED VIRUS-DELIVERED SINGLE-CUT CRISPR simplified abstract (The Board of Regents of The University of Texas System) (20240711)
  • 20240165271. NUCLEOTIDE EDITING TO REFRAME DMD TRANSCRIPTS BY BASE EDITING AND PRIME EDITING simplified abstract (The Board of Regents of The University of Texas System) (20240523)
  • 20240325454. GENOMIC EDITING OF RBM20 MUTATIONS simplified abstract (The Board of Regents of The University of Texas System) (20241003)

Rhonda BASSEL-DUBY of Dallas TX (US)

• Number of Gene Editing patents: 3
• Top companies:
  • The Board of Regents of The University of Texas System: 3 patents
• Recent patents:
  • 20240226334. CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS WITH ALL-IN-ONE ADENO-ASSOCIATED VIRUS-DELIVERED SINGLE-CUT CRISPR simplified abstract (The Board of Regents of The University of Texas System) (20240711)
  • 20240165271. NUCLEOTIDE EDITING TO REFRAME DMD TRANSCRIPTS BY BASE EDITING AND PRIME EDITING simplified abstract (The Board of Regents of The University of Texas System) (20240523)
  • 20240325454. GENOMIC EDITING OF RBM20 MUTATIONS simplified abstract (The Board of Regents of The University of Texas System) (20241003)

Théophile OHLMANN

• Number of Gene Editing patents: 3
• Top companies:
  • Institut National De La Sante Et De La Recherche Medicale (INSERM): 3 patents
• Recent patents:
  • 20240228546. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM)) (20240711)
  • 20240132547. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM)) (20240425)
  • 20240109940. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM)) (20240404)

Philippe MANGEOT

• Number of Gene Editing patents: 3
• Top companies:
  • Institut National De La Sante Et De La Recherche Medicale (INSERM): 3 patents
• Recent patents:
  • 20240228546. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM)) (20240711)
  • 20240132547. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM)) (20240425)
  • 20240109940. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM)) (20240404)

Emiliano RICCI

• Number of Gene Editing patents: 3
• Top companies:
  • Institut National De La Sante Et De La Recherche Medicale (INSERM): 3 patents
• Recent patents:
  • 20240228546. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM)) (20240711)
  • 20240132547. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM)) (20240425)
  • 20240109940. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM)) (20240404)

Andrew Garst of San Diego CA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • VedaBio, Inc.: 3 patents
• Recent patents:
  • 20240228993. ENGINEERED NUCLEIC ACID-GUIDED NUCLEASES simplified abstract (VedaBio, Inc.) (20240711)
  • 20240344044. DELIVERY OF THERAPEUTICS IN VIVO VIA A CRISPR-BASED CASCADE SYSTEM simplified abstract (VedaBio, Inc.) (20241017)
  • 20240110164. DELIVERY OF THERAPEUTICS IN VIVO VIA A CRISPR-BASED CASCADE SYSTEM simplified abstract (VedaBio, Inc.) (20240404)

Hiroshi Nishimasu

• Number of Gene Editing patents: 3
• Top companies:
  • Massachusetts Institute of Technology: 2 patents
  • The Broad Institute, Inc.: 1 patents
• Recent patents:
  • 20240229023. RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX simplified abstract (Massachusetts Institute of Technology) (20240711)
  • 20240132883. RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX simplified abstract (Massachusetts Institute of Technology) (20240425)
  • 20240035006. CRYSTAL STRUCTURE OF CRISPR CPF1 simplified abstract (The Broad Institute, Inc.) (20240201)

Jonathan M. LEVY of Brookline MA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • PRIME MEDICINE, INC.: 2 patents
  • Prime Medicine, Inc.: 1 patents
• Recent patents:
  • 20240229038. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE simplified abstract (PRIME MEDICINE, INC.) (20240711)
  • 20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE simplified abstract (PRIME MEDICINE, INC.) (20240523)
  • 20240067940. METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES simplified abstract (Prime Medicine, Inc.) (20240229)

Aaron Nakwon CHANG of Lexington MA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • PRIME MEDICINE, INC.: 3 patents
• Recent patents:
  • 20240229038. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE simplified abstract (PRIME MEDICINE, INC.) (20240711)
  • 20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS simplified abstract (PRIME MEDICINE, INC.) (20240912)
  • 20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE simplified abstract (PRIME MEDICINE, INC.) (20240523)

Villads Egede Johansen

• Number of Gene Editing patents: 3
• Top companies:
  • NIL Technology ApS: 3 patents
• Recent patents:
  • 20240230951. DEVICES INCLUDING AN OPTICAL METASTRUCTURE, AND METHODS FOR DESIGNING METASTRUCTURES simplified abstract (NIL Technology ApS) (20240711)
  • 20240272448. OPTICAL IMAGING DEVICES INCORPORATING A METALENS TO FACILITATE ZOOMING OPERATIONS simplified abstract (NIL Technology ApS) (20240815)
  • 20240337774. MULTI-CHANNEL HIGH-RESOLUTION IMAGING DEVICES INCORPORATING METALENSES FOR COLOR IMAGES simplified abstract (NIL Technology ApS) (20241010)

Jason FERNANDES of Redwood City CA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Scribe Therapeutics Inc.: 3 patents
• Recent patents:
  • 20240123089. COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9 simplified abstract (Scribe Therapeutics Inc.) (20240418)
  • 20240124537. COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9 simplified abstract (Scribe Therapeutics Inc.) (20240418)
  • 20240254466. ENGINEERED CLASS 2, TYPE V REPRESSOR SYSTEMS simplified abstract (Scribe Therapeutics Inc.) (20240801)

Ross WHITE of Concord CA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Scribe Therapeutics Inc.: 3 patents
• Recent patents:
  • 20240123089. COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9 simplified abstract (Scribe Therapeutics Inc.) (20240418)
  • 20240124537. COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9 simplified abstract (Scribe Therapeutics Inc.) (20240418)
  • 20240254466. ENGINEERED CLASS 2, TYPE V REPRESSOR SYSTEMS simplified abstract (Scribe Therapeutics Inc.) (20240801)

Emeric Jean Marius CHARLES of Berkeley CA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Scribe Therapeutics Inc.: 3 patents
• Recent patents:
  • 20240123089. COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9 simplified abstract (Scribe Therapeutics Inc.) (20240418)
  • 20240124537. COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9 simplified abstract (Scribe Therapeutics Inc.) (20240418)
  • 20240254466. ENGINEERED CLASS 2, TYPE V REPRESSOR SYSTEMS simplified abstract (Scribe Therapeutics Inc.) (20240801)

Addison WRIGHT of El Cerrito CA (US)

• Number of Gene Editing patents: 3
• Top companies:
  • Scribe Therapeutics Inc.: 3 patents
• Recent patents:
  • 20240123089. COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9 simplified abstract (Scribe Therapeutics Inc.) (20240418)
  • 20240124537. COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9 simplified abstract (Scribe Therapeutics Inc.) (20240418)
  • 20240033377. AAV VECTORS FOR GENE EDITING simplified abstract (Scribe Therapeutics Inc.) (20240201)

Top Collaborations in Gene Editing

Top US States for Gene Editing Inventors

Top Cities for Gene Editing Inventors

• Cambridge: 243 inventors
• San Diego: 72 inventors
• San Francisco: 57 inventors
• Boston: 57 inventors
• New York: 48 inventors
• London: 38 inventors
• Durham: 37 inventors
• Seattle: 36 inventors
• Zwijnaarde: 35 inventors
• Seoul: 33 inventors
• Shanghai: 32 inventors
• Wuhan: 29 inventors
• Oakland: 29 inventors
• Beijing: 28 inventors
• Berkeley: 28 inventors
• Wuxi: 28 inventors
• Philadelphia: 26 inventors
• Worcester: 25 inventors
• Daejeon: 25 inventors
• Hangzhou: 23 inventors